Basic Materials / Specialty ChemicalsNYSE
$316.82
+0.00 (+0.00%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 25% · confianza 25%
FCF escenarios
weak_data · normalized FCF n/d · quality 42.0/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
13/100
F
Piotroski
4/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
20/100
SEC 0%
Sin guardar todavía.
Market Cap
$78.1B
P/E
N/A
•EV/EBITDA
N/A
•ROE
55.9%
↑Gross Margin
48.8%
↑Debt/Equity
2.03
↑Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2007–2025 · 18 años de histórico normalizado
Revenue CAGR
+6.2%
FCF CAGR
—
FCF margin
—
FCF / Net income
—
Latest source
Provider fallback
Margin decomposition
Último año: revenue $23.57B · net income $2.57B · FCF —
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||||||||||||
| Revenue | $23.57B | $23.57B | $23.10B | $23.05B | $22.15B | $19.94B | $18.36B | $17.90B | $17.53B | $14.98B | $11.86B | $11.34B | $11.13B | $10.19B | $9.53B | $8.77B | $7.78B | $7.09B | $7.98B | $8.01B |
| Net Income | $2.57B | $2.57B | $2.68B | $2.39B | $2.02B | $1.86B | $2.03B | $1.54B | $1.11B | $1.73B | $1.13B | $1.05B | $865.9M | $752.6M | $631.0M | $441.9M | $462.5M | $435.8M | $476.9M | $615.6M |
| EPS | 10.26 | 10.26 | 10.55 | 9.25 | 7.72 | 6.98 | 7.36 | 5.50 | 11.67 | 18.20 | 11.99 | 11.15 | 8.77 | 7.26 | 6.02 | 4.14 | 4.21 | 3.78 | 4.00 | 4.70 |
| Gross Margin | 48.8% | 48.8% | 48.5% | 46.7% | 42.1% | 42.8% | 47.3% | 44.9% | 42.3% | 44.8% | 49.9% | 49.0% | 46.4% | 45.3% | 44.1% | 42.7% | 44.8% | 46.0% | 43.8% | 45.0% |
| Operating Margin | — | — | — | 18.1% | 15.3% | 15.5% | 18.4% | 15.7% | 14.9% | 14.9% | 18.3% | 17.3% | 15.2% | 14.2% | 13.7% | 11.2% | 12.2% | — | — | — |
| Net Margin | 10.9% | 10.9% | 11.6% | 10.4% | 9.1% | 9.3% | 11.1% | 8.6% | 6.3% | 11.5% | 9.6% | 9.3% | 7.8% | 7.4% | 6.6% | 5.0% | 5.9% | 6.1% | 6.0% | 7.7% |
| Balance Sheet | ||||||||||||||||||||
| Debt/Equity | 2.03 | 2.03 | 2.02 | 2.25 | 3.09 | 3.52 | 2.29 | 1.95 | 2.33 | 2.71 | 0.64 | 2.20 | 1.12 | 0.63 | 0.91 | — | 0.40 | 0.52 | 0.19 | 0.16 |
| Cash Flow | ||||||||||||||||||||
| Free Cash Flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | $581.4M | $767.9M | $759.0M | $708.7M |
| Returns | ||||||||||||||||||||
| ROE | 55.9% | 55.9% | 66.2% | 64.3% | 65.1% | 76.5% | 56.2% | 37.4% | 29.7% | 47.4% | 60.3% | 121.4% | 86.9% | 42.4% | 35.2% | — | 28.7% | 29.2% | 29.7% | 34.5% |
| Growth & Yield | ||||||||||||||||||||
| Revenue Growth | 2.1% | 2.1% | 0.2% | 4.1% | 11.1% | 8.6% | 2.6% | 2.1% | 17.0% | 26.4% | 4.6% | 1.9% | 9.3% | 6.8% | 8.8% | 12.7% | 9.6% | -11.1% | -0.3% | — |
| EPS Growth | -2.7% | -2.7% | 14.1% | 19.8% | 10.6% | -5.2% | 33.8% | -52.9% | -35.9% | 51.8% | 7.5% | 27.1% | 20.8% | 20.6% | 45.4% | -1.7% | 11.4% | -5.5% | -14.9% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
39.9%
EPS terminal req.
$28.11
Spread vs growth
-42.7%
5Y implied EPS CAGR
27.1%
EPS terminal req.
$34.02
Spread vs growth
-29.8%
10Y implied EPS CAGR
18.2%
EPS terminal req.
$54.78
Spread vs growth
-21.0%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Unavailable: positive start/end prices are required.